Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Piramal patents EZH2 inhibitors

Oct. 20, 2014

Novel FABP inhibitors synthesized by Roche

Oct. 17, 2014

Novel IDO inhibitors disclosed by Bristol-Myers Squibb

Oct. 17, 2014

Scientists at Global Blood Therapeutics divulge novel prodrugs for sickle cell disease

Oct. 17, 2014

Bayer Schering Pharma patents new Wnt signaling inhibitors for cancer

Oct. 17, 2014

Novel Nav1.7 blockers divulged by Genentech and Xenon Pharmaceuticals

Oct. 16, 2014

Researchers at Aptose Biosciences patent new agents for cancer

Oct. 16, 2014

New BUB1 inhibitors disclosed by Bayer Schering Pharma for cancer

Oct. 16, 2014

Purdue Pharma patents novel Nav1.7 blockers for pain

Oct. 16, 2014

Seragon Pharmaceuticals designs novel ER-alpha ligands for cancer and other disorders

Oct. 15, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...